PTPN1 and cardiac hypertrophy: Pharmacological inhibition or genetic deletion of PTP1B improved heart failure due to the beneficial effects on cardiac remodelling, such as increased contractile function, and a decrease in cardiac hypertrophy in fibrosis [31].